Skip to main content
. 2023 Oct 27;10(11):ofad526. doi: 10.1093/ofid/ofad526

Figure 2.

Figure 2.

Meta-analysis estimates of virologic failure (VF) incidence after switch to dolutegravir plus lamivudine in people with human immunodeficiency virus type 1 with (A) and without (B) historical M184V/I from systematic literature review–identified real-world evidence studies, inclusive of all VF definitions. Abbreviations: CI, confidence interval; PWH, people with human immunodeficiency virus type 1; VF, virologic failure; Wt, weight.